Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounceā„¢ Thrombectomy System

Author's Avatar
Apr 20, 2023

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced enrollment of the first patient in PROWL, the Pounceā„¢ Thrombectomy System Retrospective Registry.